Elevated brain amyloid level associated with increased likelihood of cognitive decline

Elevated brain amyloid level associated with increased likelihood of cognitive decline Among a group of cognitively normal individuals, those who had elevated levels in the brain of the protein amyloid were more likely to experience cognitive decline in the following years, according to a study. Elevated brain amyloid level associated with increased likelihood of cognitive…

Alzheimer's disease patients with psychosis more likely to be misdiagnosed, study suggests

Alzheimer’s disease patients with psychosis more likely to be misdiagnosed, study suggests People with Alzheimer’s disease who experience psychosis — including delusions and hallucinations — are five times more likely to be misdiagnosed with dementia with Lewy bodies compared to patients who do not, new research suggests. Alzheimer’s disease patients with psychosis more likely to…

Whole-body vibration training improves balance control and sit-to-stand performance among middle-aged and older adults: a pilot randomized controlled trial

Whole-body vibration training improves balance control and sit-to-stand performance among middle-aged and older adults: a pilot randomized controlled trial Aging is associated with decreased balance, which increases falling risk. The objective of the current study was to determine the feasibility and effects of whole-body vibration (WBV) training on knee extensor… Whole-body vibration training improves balance…

Good nutrition, physical training and mental exercises can reverse physical frailty in the elderly

Good nutrition, physical training and mental exercises can reverse physical frailty in the elderly Physical frailty is common among the elderly and is strongly associated with cognitive impairment, dementia and adverse health outcomes such as disability, hospitalisation, and mortality. A four-year study showed that a combination of nutritional, physical and cognitive interventions can reverse physical…

Gene variant protecting against Alzheimer's disease decreases plasma beta-amyloid levels

Gene variant protecting against Alzheimer’s disease decreases plasma beta-amyloid levels The APP gene variant protecting against Alzheimer’s disease significantly decreases plasma beta-amyloid levels in a population cohort. This is a very significant discovery, as many on-going drug trials in the field of Alzheimer’s disease focus on decreasing beta-amyloid levels in the brain tissue. According to…